Overview
Corentin Spriet practices practicing medicine in Lille, France.
Mr. Spriet is highly rated in 1 condition, according to our data. His clinical expertise encompasses TMEM165-CDG, Brain Stem Cancer, and Prostate Cancer.
He is actively involved in clinical research, co-authoring 47 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Corentin Spriet
Is Corentin Spriet a top-rated expert for TMEM165-CDG?
MediFind is an objective health platform that identifies experts based on real-world data. Corentin Spriet is classified as an Advanced expert for TMEM165-CDG, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Corentin Spriet participate in research or clinical trials?
Yes. Corentin Spriet has published 47 articles and abstracts on conditions like TMEM165-CDG. You can view a list of Corentin Spriet's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- TMEM165-CDGMr. Spriet isAdvanced. Learn about TMEM165-CDG.
- Experienced
- Brain Stem CancerMr. Spriet isExperienced. Learn about Brain Stem Cancer.
- Prostate CancerMr. Spriet isExperienced. Learn about Prostate Cancer.